Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs). [Phase 2]

View source ↗

Summary

Phase II prospective randomized proof-of-concept study evaluating a personalized dietary intervention in women with advanced gynecologic cancer or breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: TNC Nutrición Terapéutica S.L. | Conditions: Gynecologic Cancers, Advanced Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING